TRDA
Entrada Therapeutics Inc
NASDAQ: TRDA · HEALTHCARE · BIOTECHNOLOGY
$14.50
+7.41% today
Updated 2026-05-01
Market cap
$503.12M
P/E ratio
—
P/S ratio
19.79x
EPS (TTM)
$-3.47
Dividend yield
—
52W range
$5 – $14
Volume
0.2M
Entrada Therapeutics Inc (TRDA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+7.7%
Last 4 quarters
Revenue YoY growth
-96.5%
Most recent quarter
EPS YoY growth
-3233.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+10.3%
2025-11-11
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.94 | +18.7% | $11.98 | $11.93 | -0.4% |
| 2025-11-11 | $-1.06 | -6.9% | $7.26 | $8.01 | +10.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.16 | $-0.94 | +18.7% | $1.30M | -96.5% |
| 2025-09-30 | $-0.99 | $-1.06 | -6.9% | $1.61M | -91.8% |
| 2025-06-30 | $-0.82 | $-1.04 | -26.8% | $1.95M | -97.9% |
| 2025-03-31 | $-0.78 | $-0.42 | +45.8% | $20.56M | -65.2% |
| 2024-12-31 | $-0.67 | $0.03 | +104.5% | $37.40M | -10.6% |
| 2024-09-30 | $-0.73 | $-0.35 | +52.1% | $19.57M | -55.3% |
| 2024-06-30 | $0.14 | $1.55 | +1007.1% | $94.69M | +421.2% |
| 2024-03-31 | $-0.59 | $0.68 | +215.3% | $59.12M | +134.0% |
| 2023-12-31 | $-0.17 | $-0.29 | -70.6% | $41.85M | — |
| 2023-09-30 | $-0.74 | $1.02 | +237.8% | $43.73M | — |
| 2023-06-30 | $-0.69 | $-0.78 | -13.0% | $18.17M | — |
| 2023-03-31 | $0.97 | $-0.21 | -121.6% | $25.26M | — |
Frequently asked questions
Has Entrada Therapeutics Inc beaten earnings estimates?
Entrada Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +7.7% over the last 4 quarters.
How does TRDA stock react to earnings?
TRDA stock has moved an average of +5.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Entrada Therapeutics Inc's revenue growth rate?
Entrada Therapeutics Inc reported year-over-year revenue growth of -96.5% in its most recent quarter, with EPS growing -3233.3% year-over-year.